Keyphrases
Receptor Antagonist
100%
Neurological Outcome
100%
Intracerebral Hemorrhage
100%
TNF Receptor 1 (TNFR1)
100%
Therapeutic Target
18%
Neurovascular Injury
18%
Receptor Complex
9%
Pharmacological Inhibitors
9%
Edema
9%
Treatment Options
9%
Clinical Utility
9%
Beneficial Effects
9%
Most Common Form
9%
Cell Permeable
9%
Improved Outcomes
9%
Patient Outcomes
9%
Neurological Injury
9%
Hemorrhagic Stroke
9%
Neurological Deficit
9%
Long-term Prognosis
9%
Stroke Subtypes
9%
Adjunct Therapy
9%
Hematoma Volume
9%
Acute Mortality
9%
Inflammatory Activity
9%
Blood-brain Barrier Opening
9%
Clot Formation
9%
Patient Deterioration
9%
Triazoloquinoxaline
9%
Neuroscience
Receptor Antagonist
100%
Cerebral Hemorrhage
100%
Tumor Necrosis Factor Alpha
100%
Tumor Necrosis Factor Receptor
50%
Blood Brain Barrier
8%
Adjuvant Therapy
8%
Hematoma
8%
Coagulation System
8%